【摘要】 目的探讨参松养心胶囊与胺碘酮联合治疗心律失常的临床效果。方法 60例心律失常患者作为研究对象,根据患者意愿分为对照组和观察组,每组30例。观察组接受参松养心胶囊和胺碘酮治疗,对照组仅接受胺碘酮治疗,比较两组治疗效果及不良反应。结果观察组和对照组总有效率分别为90.0%和66.7%,组间差异具有统计学意义(P<0.05);观察组和对照组不良反应发生率分别为10.0%和16.7%,组间差异无统计学意义(P>0.05)。结论参松养心胶囊与胺碘酮联合用药可提升心律失常控制效果,值得推广使用。更多还原

【Abstract】 Objective To investigate the clinical effect by Shensongyangxin capsule combined with amiodarone in the treatment of arrhythmia. Methods There were 60 patients with arrhythmia as study subjects. They were divided by their willingness into control group and observation group, with 30 cases in each group. The observation group received Shensongyangxin capsule combined with amiodarone for treatment, and the control group received amiodarone. Curative effects and adverse reactions of the two groups were compared. Results The total effective rates of the observation group and control group were respectively 90.0% and 66.7%, and the difference between the two groups had statistical significance(P<0.05). The observation group and control group had incidences of adverse reactions as 10.0% and 16.7%, and their difference had no statistical significance(P>0.05). Conclusion Combination of Shensongyangxin capsule and amiodarone can improve control effect on arrhythmia, and this method is worthy of promotion and application.更多还原